These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29061405)

  • 1. Role of Ketamine in Severe Depression with suicidal ideation - Insights from a Case Study.
    Gurnani T; Khurshid KA
    Asian J Psychiatr; 2017 Oct; 29():112-113. PubMed ID: 29061405
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral ketamine augmentation for chronic suicidality in treatment-resistant depression.
    De Gioannis A; De Leo D
    Aust N Z J Psychiatry; 2014 Jul; 48(7):686. PubMed ID: 24452289
    [No Abstract]   [Full Text] [Related]  

  • 3. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.
    Ionescu DF; Bentley KH; Eikermann M; Taylor N; Akeju O; Swee MB; Pavone KJ; Petrie SR; Dording C; Mischoulon D; Alpert JE; Brown EN; Baer L; Nock MK; Fava M; Cusin C
    J Affect Disord; 2019 Jan; 243():516-524. PubMed ID: 30286416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urgent ketamine infusion rapidly eliminated suicidal ideation for a patient with major depressive disorder: a case report.
    Zigman D; Blier P
    J Clin Psychopharmacol; 2013 Apr; 33(2):270-2. PubMed ID: 23422387
    [No Abstract]   [Full Text] [Related]  

  • 5. Promises and concerns regarding the use of ketamine and esketamine in the treatment of depression.
    Pérez-Esparza R; Kobayashi-Romero LF; García-Mendoza AM; Lamas-Aguilar RM; Fonseca-Perezamador A
    Acta Psychiatr Scand; 2019 Aug; 140(2):182-183. PubMed ID: 31251388
    [No Abstract]   [Full Text] [Related]  

  • 6. Suicidality in treatment resistant depression: perspective for ketamine use.
    Jakuszkowiak-Wojten K; Gałuszko-Węgielnik M; Wilkowska A; Słupski J; Włodarczyk A; Górska N; Szarmach J; Szałach ŁP; Wiglusz MS; Krysta K; Cubała WJ
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):258-260. PubMed ID: 31488737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study.
    Ionescu DF; Swee MB; Pavone KJ; Taylor N; Akeju O; Baer L; Nyer M; Cassano P; Mischoulon D; Alpert JE; Brown EN; Nock MK; Fava M; Cusin C
    J Clin Psychiatry; 2016 Jun; 77(6):e719-25. PubMed ID: 27232360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous Ketamine as an Effective and Safe Treatment in a Suicidal Patient With Cancer Who Was Nil Per Os.
    Rajagukguk S; Lee T
    Psychosomatics; 2020; 61(4):371-374. PubMed ID: 31739996
    [No Abstract]   [Full Text] [Related]  

  • 9. Subanesthetic ketamine infusions for suicide ideation in patients with bipolar and unipolar treatment refractory depression.
    Kang MJY; Kulcar E; Chandrasena R; Anjum MR; Fairbairn J; Hawken ER; Vazquez GH
    Psychiatry Res; 2021 Feb; 296():113645. PubMed ID: 33360430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociative symptoms with intravenous ketamine in treatment-resistant depression exploratory observational study.
    Włodarczyk A; Cubała WJ; Gałuszko-Węgielnik M; Szarmach J
    Medicine (Baltimore); 2021 Jul; 100(29):e26769. PubMed ID: 34398056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine's effectiveness in unipolar versus bipolar depression.
    Fond G; Boyer L
    Psychopharmacology (Berl); 2014 Nov; 231(22):4417-8. PubMed ID: 25315362
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.
    McIntyre RS; Rosenblat JD; Nemeroff CB; Sanacora G; Murrough JW; Berk M; Brietzke E; Dodd S; Gorwood P; Ho R; Iosifescu DV; Lopez Jaramillo C; Kasper S; Kratiuk K; Lee JG; Lee Y; Lui LMW; Mansur RB; Papakostas GI; Subramaniapillai M; Thase M; Vieta E; Young AH; Zarate CA; Stahl S
    Am J Psychiatry; 2021 May; 178(5):383-399. PubMed ID: 33726522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comment on Fond and colleagues' systematic review and meta-analysis of ketamine in the treatment of depressive disorders (Psychopharmacology 2014; Jul 20 [Epub ahead of print]).
    McGirr A; Berlim MT
    Psychopharmacology (Berl); 2014 Oct; 231(19):3907-8. PubMed ID: 25176174
    [No Abstract]   [Full Text] [Related]  

  • 14. Neural correlates of suicidal ideation and its reduction in depression.
    Ballard ED; Lally N; Nugent AC; Furey ML; Luckenbaugh DA; Zarate CA
    Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25550331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In process].
    Vollmer H
    Med Monatsschr Pharm; 2016 Sep; 39(9):397-8. PubMed ID: 29956515
    [No Abstract]   [Full Text] [Related]  

  • 16. Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials.
    Ballard ED; Wills K; Lally N; Richards EM; Luckenbaugh DA; Walls T; Ameli R; Niciu MJ; Brutsche NE; Park L; Zarate CA
    J Affect Disord; 2017 Aug; 218():195-200. PubMed ID: 28477497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptic potentiation and rapid antidepressant response to ketamine in treatment-resistant major depression: A replication study.
    Nugent AC; Wills KE; Gilbert JR; Zarate CA
    Psychiatry Res Neuroimaging; 2019 Jan; 283():64-66. PubMed ID: 30551012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep as an Underused Target for Rapid Response in the Treatment of Depression and Suicidal Ideation.
    DeVylder J
    Health Soc Work; 2016 Aug; 41(3):211. PubMed ID: 29206957
    [No Abstract]   [Full Text] [Related]  

  • 19. Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression.
    Phillips JL; Norris S; Talbot J; Hatchard T; Ortiz A; Birmingham M; Owoeye O; Batten LA; Blier P
    Neuropsychopharmacology; 2020 Mar; 45(4):606-612. PubMed ID: 31759333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report.
    Bartova L; Weidenauer A; Dold M; Naderi-Heiden A; Kasper S; Willeit M; Praschak-Rieder N
    J ECT; 2017 Sep; 33(3):e31-e32. PubMed ID: 28520578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.